A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · SINGLE
- Evidence population
- Human clinical study registration
- Participants
- 46
- Population
- ALL · 70 Years to 100 Years
- Duration
- 2023-02-01 to 2025-05-31
- Intervention
- Fortimel Advanced, Nutricia; Resistance Exercise programme; Dietary advice
- Comparator
- (ii) Exercise-alone group
- Outcomes measured
- Change from baseline functional status at 12 weeks — 12 weeks; Change from baseline nutritional status at 12 weeks — 12 weeks; Adherence — 12 weeks; Muscle mass — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Muscle strength — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Five Times Sit-To-Stand test — Values at baseline will be compared to values recorded at 12 and at 24 weeks; 4 m Gait Speed test — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Change in self-reported quality of life — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Change in risk of depression — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Change in functional status — Values at baseline will be compared to values recorded at 12 and at 24 weeks; Change in baseline nutritional status at week 24 — 24 weeks; Change from baseline functional status at 24 weeks — 24 weeks; Retention — Up to 24 weeks; Recruitment — Up to 24 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.